Salwa Hindawi

1.2k total citations
56 papers, 499 citations indexed

About

Salwa Hindawi is a scholar working on Infectious Diseases, Hematology and Genetics. According to data from OpenAlex, Salwa Hindawi has authored 56 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 16 papers in Hematology and 14 papers in Genetics. Recurrent topics in Salwa Hindawi's work include Blood donation and transfusion practices (13 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Hemoglobinopathies and Related Disorders (12 papers). Salwa Hindawi is often cited by papers focused on Blood donation and transfusion practices (13 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Hemoglobinopathies and Related Disorders (12 papers). Salwa Hindawi collaborates with scholars based in Saudi Arabia, United States and Netherlands. Salwa Hindawi's co-authors include Ghazi A. Damanhouri, Esam I. Azhar, Ahmed M. Hassan, Sherif A. El‐Kafrawy, Ahmed M. Tolah, Anwar M. Hashem, Mohammad Amjad Kamal, Maha A. Badawi, Shams Tabrez and Gohar Mushtaq and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Medicine.

In The Last Decade

Salwa Hindawi

51 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salwa Hindawi Saudi Arabia 15 170 114 91 80 61 56 499
Aggrey Dhabangi Uganda 16 109 0.6× 116 1.0× 107 1.2× 110 1.4× 56 0.9× 40 776
Lealem Gedefaw Ethiopia 15 111 0.7× 349 3.1× 160 1.8× 36 0.5× 33 0.5× 26 706
Dolly Daniel India 15 69 0.4× 175 1.5× 75 0.8× 273 3.4× 28 0.5× 53 673
Mohit Chowdhry India 13 93 0.5× 159 1.4× 67 0.7× 159 2.0× 78 1.3× 74 504
Celso Spada Brazil 16 174 1.0× 74 0.6× 41 0.5× 348 4.3× 19 0.3× 39 653
Berhanu Woldu Ethiopia 10 62 0.4× 71 0.6× 36 0.4× 123 1.5× 65 1.1× 27 331
Koo‐Whang Chung United States 7 93 0.5× 125 1.1× 56 0.6× 54 0.7× 185 3.0× 7 497
Ruth Namazzi Uganda 11 55 0.3× 52 0.5× 86 0.9× 52 0.7× 22 0.4× 52 377
Dong Hee Whang South Korea 17 120 0.7× 166 1.5× 84 0.9× 187 2.3× 9 0.1× 56 876
Constantina Politis Greece 17 156 0.9× 330 2.9× 336 3.7× 125 1.6× 144 2.4× 52 871

Countries citing papers authored by Salwa Hindawi

Since Specialization
Citations

This map shows the geographic impact of Salwa Hindawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salwa Hindawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salwa Hindawi more than expected).

Fields of papers citing papers by Salwa Hindawi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salwa Hindawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salwa Hindawi. The network helps show where Salwa Hindawi may publish in the future.

Co-authorship network of co-authors of Salwa Hindawi

This figure shows the co-authorship network connecting the top 25 collaborators of Salwa Hindawi. A scholar is included among the top collaborators of Salwa Hindawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salwa Hindawi. Salwa Hindawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Badawi, Maha A., et al.. (2025). Exploring women’s capability to donate blood in a Saudi blood bank: A COM-B model study. Medicine. 104(29). e43479–e43479.
2.
Alharthi, Abdulrahman I., et al.. (2024). Plasma Exchange in Pediatric Neurology Patients: A Single-Center Experience. Cureus. 16(1). e52691–e52691.
3.
Badawi, Maha A., et al.. (2023). A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry. Journal of Clinical Apheresis. 38(5). 573–581. 2 indexed citations
4.
El‐Kafrawy, Sherif A., Ahmed M. Hassan, Ayat Zawawi, et al.. (2023). Seroprevalence of Toscana and sandfly fever Sicilian viruses in humans and livestock animals from western Saudi Arabia. One Health. 17. 100601–100601. 5 indexed citations
5.
Hindawi, Salwa, et al.. (2023). Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma.. Transfusion and Apheresis Science. 62(3). 103688–103688.
7.
El‐Beshlawy, Amal, Salwa Hindawi, Salam Alkindi, et al.. (2023). Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East. Blood Reviews. 63. 101138–101138. 8 indexed citations
8.
Burnouf, Thierry, Birgit Gathof, Evan M. Bloch, et al.. (2022). Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2. Transfusion Medicine Reviews. 36(3). 125–132. 10 indexed citations
9.
Bawazir, Waleed M., et al.. (2022). Impact of COVID‐19 on Blood Donation and Supply: A Multicenter Cross‐Sectional Study from Saudi Arabia. BioMed Research International. 2022(1). 1474426–1474426. 3 indexed citations
10.
Rajbhandary, Srijana, Chester Andrzejewski, Joy Fridey, et al.. (2022). Incorporating the entity of under‐transfusion into hemovigilance monitoring: Documenting cases due to lack of inventory. Transfusion. 62(3). 540–545. 6 indexed citations
11.
Alandijany, Thamir A., Sherif A. El‐Kafrawy, Arwa A. Faizo, et al.. (2021). Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia. Healthcare. 9(1). 51–51. 13 indexed citations
12.
Hindawi, Salwa, et al.. (2021). The impact of blood donation on blood counts and ferritin levels: A multi-center study from the Eastern Mediterranean region. Transfusion and Apheresis Science. 60(3). 103072–103072. 5 indexed citations
13.
Badawi, Maha A., et al.. (2021). Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors. Transfusion and Apheresis Science. 60(6). 103211–103211. 6 indexed citations
14.
Hindawi, Salwa, et al.. (2021). Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections. Gut Pathogens. 13(1). 29–29. 28 indexed citations
15.
Azhar, Esam I., Salwa Hindawi, Sherif A. El‐Kafrawy, et al.. (2020). Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma. Vox Sanguinis. 116(6). 673–681. 15 indexed citations
16.
Hashem, Anwar M., Sawsan S. Alamri, Ahmed M. Hassan, et al.. (2019). Development and validation of different indirect ELISAs for MERS-CoV serological testing. Journal of Immunological Methods. 466. 41–46. 15 indexed citations
17.
Jabir, Nasimudeen R., Chelapram K. Firoz, Farid Ahmed, et al.. (2017). Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease. Immunological Investigations. 46(5). 526–535. 18 indexed citations
18.
Tabrez, Shams, Nasimudeen R. Jabir, Chelapram K. Firoz, et al.. (2017). Estimation of Interleukin-1β Promoter (−31 C/T and −511 T/C) Polymorphisms and Its Level in Coronary Artery Disease Patients. Journal of Cellular Biochemistry. 118(9). 2977–2982. 13 indexed citations
19.
Tabrez, Shams, Nasimudeen R. Jabir, Chelapram K. Firoz, et al.. (2017). A putative association of interleukin‐10 promoter polymorphisms with cardiovascular disease. IUBMB Life. 69(7). 522–527. 18 indexed citations
20.
Hindawi, Salwa, Ghazi A. Damanhouri, Mohamad Saka, et al.. (2016). Detection of β-Thalassemia Mutations Using TaqMan Single Nucleotide Polymorphism Genotyping Assays. Genetic Testing and Molecular Biomarkers. 20(3). 154–157. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026